Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Enterprise Value (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Enterprise Value data on record, last reported at -$8.3 million in Q2 2025.

  • For Q2 2025, Enterprise Value rose 2.33% year-over-year to -$8.3 million; the TTM value through May 2025 reached -$8.3 million, up 2.33%, while the annual FY2025 figure was -$8.3 million, 2.33% up from the prior year.
  • Enterprise Value reached -$8.3 million in Q2 2025 per LFCR's latest filing, down from -$5.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$609000.0 in Q4 2021 and bottomed at -$19.1 million in Q2 2023.
  • Average Enterprise Value over 5 years is -$5.2 million, with a median of -$3.6 million recorded in 2022.
  • Peak YoY movement for Enterprise Value: surged 75.4% in 2021, then tumbled 1826.44% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$609000.0 in 2021, then crashed by 1016.58% to -$6.8 million in 2022, then plummeted by 180.75% to -$19.1 million in 2023, then skyrocketed by 50.47% to -$9.5 million in 2024, then increased by 12.59% to -$8.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$8.3 million in Q2 2025, -$5.4 million in Q1 2025, and -$9.5 million in Q4 2024.